VISE Seminar Fall Series – Amber Simpson, PhD
VISE Fall Seminar
to be led by
Amber Simpson, PhD
Associate Professor in Biomedical Computing and Informatics
Queen’s University, ON, Canada
Date: Thursday, September 24, 2020
Time: 12:15 p.m. Room Admittance, 12:25 p.m. start
Zoom: Details will be sent morning of…
Title: Surgical Data Science in Colorectal Liver Metastases
Abstract: Colorectal cancer is the second leading cause of cancer-related mortality in the United States. More than 50% of patients with colorectal cancer will develop liver metastases in their lifetime with a dismal <10% surviving past three years. A major therapeutic problem in this disease is that no markers prognostic of hepatic recurrence or predictive of response prior to treatment are known. The goal of this research is to fill this gap by providing non-invasive and objective prognostic imaging biomarkers for personalized treatment of colorectal liver metastases. In this talk, we contribute to the burgeoning field of surgical data science. Specifically, multi-modal integration of relevant patient data is used to determine who should undergo complex liver resection.
Short Bio: Amber Simpson is the Canada Research Chair in Biomedical Computing and Informatics, and Associate Professor jointly appointed in the Department of Biomedical and Molecular Sciences and School of Computing at Queen’s University. She is an Affiliate of the Vector Institute for AI as well as a Senior Investigator at the Canadian Cancer Trials Group. She received her PhD in Computer Science from Queen’s and was a postdoctoral fellow in the Department of Biomedical Engineering at Vanderbilt University. Recently recruited from a faculty position at Memorial Sloan Kettering Cancer Center in New York, she holds research funding from the National Institutes of Health as well funding from all three Canadian research councils (Social Sciences and Humanities Research Council of Canada, Natural Sciences and Engineering Research Council of Canada, and Canadian Institutes of Health Research). Dr. Simpson is an American Association of Cancer Research and Pancreatic Cancer Action Network award holder and a charter member of NIH study section, which recognizes her innovations in biomedical research.